Please enter both email and password to log in
You need to upgrade your Flash Player
|
You need to upgrade your Flash Player to view this content.
What's New?
New Slides on ARBITER 6—HALTS, data from the AHA 2010 Heart Disease and Stroke Statistics, and more!
Visit the slide library today to view slides featuring data from ARBITER 6—HALTS, the AHA 2010 Heart Disease and Stroke Statistics, and more, and create your own customized presentations!
|
Updates to the Current Literature Library
Easily searchable by author or keyword, our current literature library will help you to stay up-to-date with the latest clinical information!
|
Rosuvastatin Receives New Indication
The FDA has approved a new indication for the cholesterol-lowering medication, rosuvastatin (Crestor). The agent is now indicated for the primary prevention of CVD to reduce the risk of stroke, heart attack, and arterial revascularization procedures among individuals who have no clinically evident heart disease but are at increased risk due to risk factors, including age, elevated CRP, and presence of at least one additional CV risk factor.
|
FDA Issues Warning for Simvastatin
The FDA has issued a warning for simvastatin (Zocor®), the cholesterol-lowering medication. This warning pertains to the 80-mg dose of simvastatin with regard to potential for increased risk of muscle injury. For more information, click here.
|
In the News
No articles are available at this time
|
|
CCMD Co-Chairmen
|
Education Council
George L. Bakris, MD
|
Keith C. Ferdinand, MD
|
JoAnne M. Foody, MD
|
Peter Ganz, MD
|
Philip B. Gorelick, MD, MPH
|
Scott M. Grundy, MD, PhD
|
Steven M. Haffner, MD
|
John C. LaRosa, MD
|
Peter Libby, MD
|
|
|